ELENA
GALVE CALVO
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (2)
2022
2018
-
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/ HER2– advanced or metastatic breast cancer in Spain
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 773-790